- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06351046
Preventive Interventions for Chronic Pain Worsening
Study Overview
Status
Conditions
Detailed Description
Considering the need of interventions to improve pain self-management to interrupt the "pain chronification" process and the indications regarding advantages of cognitive behavioral techniques and technologic resources, the purpose of this study is to test homebased interventions connecting these two areas. Here, the effects of an online delivered standardized mindfulness-based stress reduction program and non-pharmacological techniques delivered through a virtual reality-based pain self-management program will be tested in patients with non-cancer pain lasting three months or more. Both interventions target primarily pain relief by providing pain regulating strategies.
The investigators will test the main hypothesis that participants assigned to Mindfulness-Based Stress Reduction (MBSR) or Virtual Reality-based Pain Self-management program (VRPS) present reduction of pain intensity among other outcomes at 2 months post-intervention as well as after 6-, 9-, and 12-months follow-up when compared to treatment as usual (control group).The primary aim is to investigate the effects of MBSR and VRPS on worst pain intensity in the last 24h in patients with non-cancer pain lasting 3 months or more at 2 months post-intervention.The secondary aims are to analyze the effects of both interventions on other patient-reported outcomes measures (PROMs), which are pain intensity at follow-ups, pain interference in daily activities, pain catastrophizing, pain acceptance, health-related quality of life, anxiety, depression, perceived change on over-all pain status, use of analgesic medication, and use of health care system among patients with non-cancer pain lasting 3 months or more. In addition, the effects of the two interventions will be compared.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Geana Kurita, PhD
- Phone Number: 35454797
- Email: geana.kurita@regionh.dk
Study Contact Backup
- Name: Suzanne F Forsyth Herling, PhD
- Phone Number: 35458624
- Email: suzanne.forsyth.herling.01@regionh.dk
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- At least 18 years old
- Fluent in the Danish language
- Complaint of pain lasting 3 months or more; in average pain intensity score ≥ 3 (numerical rating scale 0 to 10)
- Access to internet
- Willing and available to participate in the study.
Exclusion Criteria:
- Specialized or multidisciplinary pain treatment at baseline
- History of epilepsy
- Seizure disorder
- History of nausea or dizziness
- Hypersensitivity to flashing light or motion or other diseases that may prevent use of virtual reality equipment.
- Injury to eyes, face or neck that impedes comfortable use of virtual reality equipment.
- Current cancer disease
- Medical diagnosis of depression
- Cognitive dysfunction that interferers with compliance to the study,
- Currently pregnant or planning to become pregnant during the study period
- No access to the internet during the study period.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: MBSR program
Participants will attend online group class/week for eight consecutive weeks.
The MBSR will be based on the program adapted by the Multidisciplinary Pain Centre at Rigshospitalet (DK), which is tailored to patients with chronic pain.
Each session has duration of 1.5 hours.
Content is composed by meditation techniques and physical exercises, which focus on increasing awareness and acceptance of moment-to-moment experiences, including physical discomfort and difficult emotions.Two groups of 11-12 patients will be composed.
However, individual meetings may be organized if the recruitment process shows difficulties to gather patients in groups.
It will be delivered by a certified MBSR therapist and via Teams platform.
|
Online group class/week for eight consecutive weeks with 8 sessions
Other Names:
|
Experimental: VRPS program
VRPS is based on four evidence-based principles of cognitive-behavioral therapy and pain neuroscience education.
For this project we have selected relaxation, mindful escapes, pain distraction games, and dynamic breathing modules.The eight consecutive weeks program period of intervention is composed of one initial physical meeting with 1h duration to explain the basis/principles of the virtual tools offered, how the virtual appliance works and should be used, including safety recommendations as calm environment at home, sitting or lying position during use.
Groups of maximum 13 patients will be organized.
Patients will be instructed to use the equipment at least once a day and it can be used as many times as they wish per day aiming to reduce pain intensity or to avoid pain.
Patients will also be asked to keep a diary to register the equipment use during the study period to secure the data.
|
The VRPS has a variety of modules that can be used for pain management.
For this project we have selected relaxation, mindful escapes, pain distraction games, and dynamic breathing modules.
All modules were designed to minimize triggers of emotional distress or cybersickness.
Other Names:
|
No Intervention: Control group
Participants in the control group will not receive any of the interventions.
This study will not interfere with medical treatment plan and patients from the three groups can receive other pain treatment prescribed by physician.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain intensity
Time Frame: At baseline, 2 months, 6 months, 9 months and 12 months after intervention
|
Pain intensity for worst pain in the last 24h: Brief Pain Inventory to measure pain intensity, from no pain (0) to worst pain ever (10)
|
At baseline, 2 months, 6 months, 9 months and 12 months after intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain intensity and interference in daily activities
Time Frame: At baseline, 2 months, 6 months, 9 months and 12 months after intervention
|
Brief Pain Inventory to measure pain intensity from no pain (0) to worst pain ever (10) at follow-ups and interference on general activity, mood, walking ability, work, social relations, sleep, and enjoyment of life
|
At baseline, 2 months, 6 months, 9 months and 12 months after intervention
|
Pain catastrophizing
Time Frame: At baseline, 2 months, 6 months, 9 months and 12 months after intervention
|
Pain Catastrophizing Scale, using a 5-point Likert scale ranging from 0 (never) to 4 (always) to assess patterns of negative cognition and emotion in the context of actual or anticipated pain
|
At baseline, 2 months, 6 months, 9 months and 12 months after intervention
|
Pain acceptance
Time Frame: At baseline, 2 months, 6 months, 9 months and 12 months after intervention
|
Chronic Pain Acceptance Questionnaire to assess engagement in activity (despite pain), pain willingness, and total pain acceptance score, using a rating scale from 0 to 6.
Never true (0) to always true (6)
|
At baseline, 2 months, 6 months, 9 months and 12 months after intervention
|
Health status
Time Frame: At baseline, 2 months, 6 months, 9 months and 12 months after intervention
|
patient-generated outcome assessed by the Measure Yourself Medical Outcome Profile (MYMOP2), which measures effects from health care interventions on physical, emotional, or social symptoms/problems.
It is problem-specific and includes general wellbeing
|
At baseline, 2 months, 6 months, 9 months and 12 months after intervention
|
Health related quality of life
Time Frame: At baseline, 2 months, 6 months, 9 months and 12 months after intervention
|
Physical functioning, role limitations due to physical health, role limitations due to emotional problems, energy/fatigue, emotional well-being, social functioning, pain, and general health using the RAND 36-Item Short Form Health Survey version 1.0.
First, precoded numeric values are recoded per the scoring key.
All items are scored so that a high score defines a more favorable health state.
In addition, each item is scored on a 0 to 100 range so that the lowest and highest possible scores are 0 and 100, respectively.
|
At baseline, 2 months, 6 months, 9 months and 12 months after intervention
|
Anxiety
Time Frame: At baseline, 2 months, 6 months, 9 months and 12 months after intervention
|
General Anxiety Disorder - 7 (GAD-7) is commonly used as a measure of general anxiety severity.
Measured on a rating scale,- "from not at all" (0) to "almost every day" (3)
|
At baseline, 2 months, 6 months, 9 months and 12 months after intervention
|
Depression
Time Frame: At baseline, 2 months, 6 months, 9 months and 12 months after intervention
|
Patient Health Questionnaires scale (PHQ-9) can help track a patient's overall depression severity as well as track the improvement of specific symptoms with treatment.
Measured on a rating scale,- from "not at all" (0) to "almost every day" (3)
|
At baseline, 2 months, 6 months, 9 months and 12 months after intervention
|
Use of medication
Time Frame: At baseline, 2 months, 6 months, 9 months and 12 months after intervention
|
Medication used (type and quantity) The information collected will refer to the period from patient inclusion to up one year follow-up.
|
At baseline, 2 months, 6 months, 9 months and 12 months after intervention
|
Use of healthcare system
Time Frame: At baseline, 2 months, 6 months, 9 months and 12 months after intervention
|
The number of times that he/she used the health care system because of his chronic pain problem and treatment received (pharmacologic, surgical, rehabilitation, etc.).
The information collected will refer to the period from patient inclusion to up one year follow-up.
|
At baseline, 2 months, 6 months, 9 months and 12 months after intervention
|
Number of absent days at work
Time Frame: At baseline, 2 months, 6 months, 9 months and 12 months after intervention
|
Number of absent days at work because of pain will be asked directly to the patients through the electronic forms.
The information collected will refer to the period from patient inclusion to up one year follow-up.
|
At baseline, 2 months, 6 months, 9 months and 12 months after intervention
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Satisfaction with the intervention
Time Frame: At baseline, 2 months, 6 months, 9 months and 12 months after intervention
|
Satisfaction with the interventions will be asked to the intervention groups by general questions about the intervention experienced with answers in a 6-point scale (0=completely dissatisfied to 5= completely satisfied) and there will be space to write comments.
|
At baseline, 2 months, 6 months, 9 months and 12 months after intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Geana Kurita, PhD, Rigshospitalet, Denmark
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NCT05178082_WP3
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Non-Cancer Pain
-
Rigshospitalet, DenmarkThe Novo Nordic FoundationRecruitingChronic Non-Cancer PainDenmark
-
University of California, Los AngelesUnknownNon-Cancer Chronic PainUnited States
-
Uppsala UniversityRecruitingChronic Non-Cancer PainSweden
-
Cosima LocherBrown University; University of BaselNot yet recruiting
-
University of WashingtonNational Institute on Drug Abuse (NIDA)Completed
-
Janssen PharmaceuticaWithdrawnModerate to Severe Chronic Non-cancer Pain
-
Icahn School of Medicine at Mount SinaiEndo PharmaceuticalsUnknownNeuropathic Pain | Non-cancer Pain | Chronic Nociceptive PainUnited States
-
DurectCompletedChronic, Non Malignant PainUnited States
-
Centre Hospitalier Universitaire de NīmesWithdrawn
-
Norwegian University of Science and TechnologyCompletedNon-malignant Chronic Pain
Clinical Trials on Online Mindfullness Based Stress Reduction Program
-
University of California, Los AngelesNational Center for Complementary and Integrative Health (NCCIH); VA Medical...UnknownPost Traumatic HeadacheUnited States
-
Amasya UniversityCompletedAnxiety | Pregnancy RelatedTurkey
-
Amasya UniversityCompletedStress | Pregnancy, High RiskTurkey
-
San Jose State UniversityRecruitingPsychophysiologic Reaction | Mindfulness | Behavior, HealthUnited States
-
Amasya UniversityCompletedAnxiety | Pregnancy RelatedTurkey
-
Aleksandra Eriksen IshamUniversity of AarhusCompletedDepression | Mindfulness-Based Stress ReductionUnited Kingdom
-
University of Massachusetts, WorcesterNational Center for Complementary and Integrative Health (NCCIH); BrightOutcome...CompletedPain, ChronicUnited States
-
Ataturk UniversityCompleted
-
Necmettin Erbakan UniversityActive, not recruitingDEPRESSION | ANXIETY | STRESS | HOPELESSNESS | MİNDFULNESSTurkey
-
Ankara UniversityCompletedBreast Cancer | Nursing CariesTurkey